Pazopanib for the treatment of soft-tissue sarcoma

Pazopanib is a multikinase inhibitor which potently inhibits the activity of major receptor tyrosine kinases, including vascular endothelial growth factor receptor-1, vascular endothelial growth factor receptor-2, vascular endothelial growth factor receptor-3, platelet-derived growth factor receptor...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Heudel, Pierre, Cassier, Philippe, Derbel, Olfa, Dufresne, Armelle, Meeus, Pierre, Thiesse, Philippe, Ranchère-Vince, Dominique, Blay, Jean Yves, Ray-Coquard, Isabelle
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2012
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3508654/
https://ncbi.nlm.nih.gov/pubmed/23204874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S33195
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires